BioSpace News Archive

Pharm Country

Bernoulli Enterprise, Inc. Integrates Cybersecurity Framework v. 1.1

Framework adoption prepares Bernoulli’s market-leading surveillance platform and corporate infrastructure to meet evolving cyber threats

December 11, 2018
·
3 min read
Business

Walgreens Boots Alliance Schedules Fiscal 2019 First Quarter Earnings Announcement for December 20, 2018

Results at 7 a.m. Eastern time Thursday, December 20, 2018 followed by a one-hour conference call with Walgreens Boots Alliance management beginning at 8:30 a.m. Eastern time.

December 11, 2018
·
3 min read
Business

2019 Catalyst Award for Top New Hire Now Accepting Applications

The award showcases young employees who have contributed to the growth of Canada’s bio-economy while highlighting biotech companies as Employers of Choice.

December 11, 2018
·
2 min read
Business

Orbis and Mercer University to Launch New ABSN Program in Atlanta

The partners will launch an Accelerated Bachelor of Science in Nursing (ABSN) program that offers qualified students in the Atlanta area a new, faster path into the high demand nursing profession.

December 11, 2018
·
4 min read
Business

Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead

The BiSAb program leverages the company’s artificial intelligence platform, EDGETM, for the identification and prioritization of highly tumor-specific antigens, including neoantigens, shared between patients with various solid tumors.

December 11, 2018
·
4 min read
World-first Approval For Multiple Myeloma Drug APLIDIN(R)

Australia’s Therapeutic Goods Administration approves APLIDIN (plitidepsin) for relapsed/refractory multiple myeloma patients

December 11, 2018
·
6 min read
Cerecin Sponsors and Presents at Alzheimer’s Disease Therapeutics: Alternatives to Amyloid Symposium

Dr. Samuel Henderson, Cerecin’s Chief Scientific Officer, will present rationale and evidence for ketogenic therapies in Alzheimer’s disease

December 11, 2018
·
3 min read
Business

Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA® Xsail®

Optinose is a global specialty pharmaceutical company focused on serving the needs of patients cared for by ear, nose and throat (ENT) and allergy specialists.

December 11, 2018
·
2 min read
Neovasc Announces Positive 12-year Follow-up Data for Neovasc Reducer; as Published in JACC

The publication is entitled: “First-in-Human Use of Coronary Sinus Reducer in Patients With Refractory Angina.”

December 11, 2018
·
10 min read
Policy

Non–Cystic Fibrosis Bronchiectasis (NCFB) FDA Grants “Fast-Track” and “QIPD” to Zambon for Colistimethate Sodium Powder for Nebulizer Solution Delivered by the I-neb AAD System

Non–Cystic Fibrosis Bronchiectasis (NCFB) is a, chronic, progressive and irreversible disease, prevalent in Europe and the US.

December 11, 2018
·
5 min read